Nichi-Iko Pharmaceutical Co Ltd represents a commitment to delivering high-quality pharmaceutical products and improving patient's lives. With a strong corporate philosophy focused on integrity, innovation, and patient-centeredness, Nichi-Iko aims to contribute to society by providing safe and effective medications. The company has a holistic approach towards healthcare, ensuring accessibility and affordability of their products. Nichi-Iko prioritizes customer satisfaction, continuous research and development, and collaborative partnerships to address the evolving medical needs of patients. Through their dedication to quality, Nichi-Iko Pharmaceutical Co Ltd strives to create a positive impact in the pharmaceutical industry and enhance the well-being of people worldwide.

Nichi-Iko Pharmaceutical Co Ltd is primarily present in Japan, where it is headquartered. As a prominent pharmaceutical company, Nichi-Iko focuses on the manufacturing and distribution of generic drugs. With its strong presence in the Japanese market, Nichi-Iko serves a significant role in providing affordable healthcare solutions to the local population. While its primary presence is in Japan, Nichi-Iko also has a global presence through strategic collaborations and partnerships to expand its reach and contribute to the global pharmaceutical industry.

Nichi-Iko Pharmaceutical Co Ltd, a leading company in the pharmaceutical industry, has achieved several significant milestones. Over the years, the company has successfully expanded its market presence and product portfolio. It has established itself as a key player in the generic pharmaceuticals sector, offering high-quality and affordable generic drugs to the global market. Nichi-Iko Pharmaceutical Co Ltd has also achieved noteworthy growth through strategic collaborations and acquisitions, enhancing its research capabilities and market reach. These achievements have catapulted the company's reputation and positioned it as an innovative and reliable provider of pharmaceutical solutions worldwide.

Nichi-Iko Pharmaceutical Co Ltd, established in 1965, is a leading Japanese pharmaceutical company specializing in generic drugs. With its headquarters in Toyama, Japan, Nichi-Iko has a rich history of over 55 years in the industry. The company focuses on research and development, production, and sales of high-quality, affordable medications. Nichi-Iko aims to contribute towards better healthcare by providing accessible treatment options to patients worldwide. Over the years, Nichi-Iko has expanded its global presence through strategic partnerships and acquisitions, strengthening its position as a trusted provider of generic pharmaceuticals. Today, the company continues to innovate and drive advancements in the pharmaceutical field, forging a path towards a healthier future.

The main competitors of Nichi-Iko Pharmaceutical Co Ltd in the market include Towa Pharmaceutical Co Ltd, Sawai Pharmaceutical Co Ltd, and Eisai Co Ltd. These companies are recognized players in the pharmaceutical industry and pose notable competition to Nichi-Iko Pharmaceutical Co Ltd. Their presence and product offerings contribute to a competitive landscape within the market.

Nichi-Iko Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

The business model of Nichi-Iko Pharmaceutical Co Ltd focuses on the development, manufacturing, and sales of generic pharmaceutical products. As one of Japan's leading generic drug manufacturers, Nichi-Iko aims to provide affordable and high-quality medications to a wide range of patients. The company places great emphasis on research and development, ensuring the constant improvement and expansion of their product portfolio. Through strategic partnerships and acquisitions, Nichi-Iko continues to strengthen its position in the global pharmaceutical market, while maintaining a strong commitment to meeting the healthcare needs of individuals worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ Nichi-Iko Pharmaceutical Co هو ؜-٠٫٠٢.

مُعامِل القيمة إلى المبيعات Nichi-Iko Pharmaceutical Co هو ٠٫٠١.

نقاط جودة AlleAktien لـ Nichi-Iko Pharmaceutical Co هي 2/10.

المتوقعة Nichi-Iko Pharmaceutical Co الإيرادات هي ٢٠١٫٨٠ مليارات JPY.

صافي الربح المتوقعة Nichi-Iko Pharmaceutical Co هو ؜-١٠٩٫٦٥ مليارات JPY.

Nichi-Iko Pharmaceutical Co Ltd is a Japanese pharmaceutical company that focuses on the manufacturing and distribution of pharmaceutical products. The company's business model is oriented towards the development, production, and marketing of generics. These medications are copies of well-known original preparations and are typically offered at a lower price. In recent years, the company has become one of the largest generic manufacturers in Japan through several acquisitions and collaborations. It also operates in the international market, including in the USA, Europe, Australia, and China. Nichi-Iko employs over 6,000 employees and operates in four main business areas: generics, biosimilars, innovative drugs, and contract manufacturing. Each of these areas has its own objectives and strategies to drive the company's growth. Generics The core business area of Nichi-Iko is the production of generics. The company offers a wide range of generic drugs used in various therapy areas such as cardiovascular diseases, gastroenterology, oncology, neurology, infectious diseases, and diabetes. Biosimilars Another important business area of Nichi-Iko is the manufacturing of biosimilars. These medications are biologics that have a similar structure and effect as originals. Nichi-Iko specializes in the development and production of biosimilars and offers them as a cost-effective alternative to expensive original preparations. Innovative drugs In addition to generics and biosimilars, Nichi-Iko also conducts research and development of innovative drugs. The company is working on the development of novel therapies for rare diseases and chronic conditions. The company's hope is to gain a competitive advantage over competitors with these products. Contract manufacturing Nichi-Iko also offers contract manufacturing (CMO) services. This includes the production of drugs for other pharmaceutical companies that do not have the capacity or technologies to manufacture them themselves. This business area has become an important driver of growth for the company. Products In addition to generics and biosimilars, Nichi-Iko offers a wide range of medications that can be used to treat various diseases. These include, among others, blood pressure-lowering medications, digestive disorders, antibiotics, painkillers, and cancer medications. The company also specializes in the production of medications for endocrinology, including drugs for the treatment of diabetes, thyroid, and adrenal gland problems. Conclusion Overall, Nichi-Iko is an innovative pharmaceutical company that specializes in the development and production of generics. Through acquisitions and collaborations, the company has become a significant player in the pharmaceutical industry and provides its products in various markets worldwide. The research and development activities of Nichi-Iko make the future of the company promising.

يوزع Nichi-Iko Pharmaceutical Co أرباحًا قدرها 0 JPY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Nichi-Iko Pharmaceutical Co في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـNichi-Iko Pharmaceutical Co هو JP3687200000.

رمز WKN لـ Nichi-Iko Pharmaceutical Co هو A0DQVE.

الرمز المُختصر لـ Nichi-Iko Pharmaceutical Co هو 4541.T.

خلال آخر 12 شهراً، دفعت Nichi-Iko Pharmaceutical Co توزيعات أرباح بقيمة ٢٠٫٠٠ JPY . وهذا يعادل عائد توزيعات أرباح يقارب ٥٧٫١٤ %. ومن المتوقع أن تدفع Nichi-Iko Pharmaceutical Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ0 JPY.

نسبة توزيعات الأرباح الحالية لـ Nichi-Iko Pharmaceutical Co هي ٥٧٫١٤ %.

Nichi-Iko Pharmaceutical Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أبريل, أكتوبر, أبريل, أكتوبر.

Nichi-Iko Pharmaceutical Co دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة 0 JPY. وهذا يعادل عائد توزيعات أرباح قدره 0 %.

Nichi-Iko Pharmaceutical Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ١٠ JPY من Nichi-Iko Pharmaceutical Co المُعلن عنها في ١‏/١٢‏/٢٠٢١، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٩‏/٩‏/٢٠٢١.

تم توزيع آخر دفعة من الأرباح بتاريخ ١‏/١٢‏/٢٠٢١.

في العام 2023، وزعت Nichi-Iko Pharmaceutical Co 0 JPY كأرباح أسهم.

يتم توزيع أرباح Nichi-Iko Pharmaceutical Co بالعملة JPY.